Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maiden, N
Right arrow Articles by Thomson, E A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maiden, N
Right arrow Articles by Thomson, E A
Ann Rheum Dis 1999;58:525-529 ( September )

Extended report

Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients? N Maiden, H A Capell, R Madhok, R Hampson, E A Thomson

Centre for Rheumatic Diseases, Royal Infirmary , Castle Street, Glasgow G4 0SF

Correspondence to: Dr H A Capell.

Accepted for publication 22 April 1999

BACKGROUND---Socioeconomic deprivation is associated with increased mortality from cardiovascular causes and malignancy. The influence of disadvantage in patients with rheumatoid arthritis (RA), who are known to have premature mortality, has not been ascertained.
AIM---To assess the relation between the level of patient deprivation and mortality in RA patients.
METHODS---200 RA patients, enrolled in a study comparing sulfasalazine and penicillamine in 1984-85, have been followed up prospectively for 12 years. Subjects were categorised into Carstairs groups with deprivation scores ranging from 1 (most affluent) to 7 (most deprived). Information about deaths was obtained from the Registrar General in Scotland, death certificates and GP/hospital records.
RESULTS---There were more RA patients in the deprived areas then expected compared with the West of Scotland and England and Wales. Some 47.5% of the RA patients had died by 12 years---the majority of cardiorespiratory causes or malignancy. There were no differences in the median age or disease duration in the various Carstairs groups at study entry, but the percentage of deaths was higher in the more deprived groups after 12 years (36% dead in most affluent area compared with 61% in the most deprived, that is, in groups 6 and 7).
CONCLUSION---In patients with RA increasing deprivation was associated with premature mortality. If confirmed elsewhere these findings have implications for rheumatological management strategies, for researchers involved in collaborative studies of patients from different socioeconomic backgrounds and for resource allocation.


© 1999 by Annals of the Rheumatic Diseases



This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
M. J. Harrison, A. Hassell, P. T. Dawes, D. L. Scott, S. M. Knight, M. J. Davis, D. Mulherin, and D. P. M. Symmons
The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practice
Rheumatology, May 1, 2007; 46(5): 849 - 855.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Bengtsson, B Nordmark, L Klareskog, I Lundberg, L Alfredsson, and the EIRA study group
Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study
Ann Rheum Dis, November 1, 2005; 64(11): 1588 - 1594.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. A. Marra, L. D. Lynd, J. M. Esdaile, J. Kopec, and A. H. Anis
The impact of low family income on self-reported health outcomes in patients with rheumatoid arthritis within a publicly funded health-care environment
Rheumatology, November 1, 2004; 43(11): 1390 - 1397.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
J Adams, J Burridge, M Mullee, A Hammond, and C Cooper
Correlation between upper limb functional ability and structural hand impairment in an early rheumatoid population
Clinical Rehabilitation, April 1, 2004; 18(4): 405 - 413.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
J Dadoniene, T Uhlig, S Stropuviene, A Venalis, A Boonen, and T K Kvien
Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania
Ann Rheum Dis, March 1, 2003; 62(3): 231 - 235.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. Symmons, G. Turner, R. Webb, P. Asten, E. Barrett, M. Lunt, D. Scott, and A. Silman
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century
Rheumatology, July 1, 2002; 41(7): 793 - 800.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. Turner, D. Symmons, A. Bamji, and T. Palferman
Consultant rheumatology workforce in the UK: changing patterns of provision 1997-2001
Rheumatology, June 1, 2002; 41(6): 680 - 684.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J Hamilton, I B McInnes, E A Thomson, D Porter, J A Hunter, R Madhok, and H A Capell
Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area
Ann Rheum Dis, June 1, 2001; 60(6): 566 - 572.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
E. S. Group
Socioeconomic deprivation and rheumatoid disease: What lessons for the health service?
Ann Rheum Dis, October 1, 2000; 59(10): 794 - 799.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
D HUTCHINSON, R J MOOTS;, H A CAPELL, N MAIDEN, R MADHOK, R HAMPSON, and E A THOMSON
Diagnostic evaluation of classification criteria for RA and reactive arthritis.
Ann Rheum Dis, May 1, 2000; 59(5): 396 - 397.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 BMJ Publishing Group Ltd & European League Against Rheumatism